Spiriva Respimat Now Approved for Asthma

Article

The FDA has added an asthma indication to Boehringer Ingelheim's tiotropium bromide inhalation spray (Spiriva Respimat).

The FDA has added an asthma indication to Boehringer Ingelheim’s tiotropium bromide inhalation spray (Spiriva Respimat).

This long-acting muscarinic antagonist (LAMA) was originally approved in September 2014 for the maintenance treatment of chronic obstructive pulmonary disease (COPD).

Two months later, the FDA started reviewing a regulatory submission to indicate Spiriva Respimat for the long-term, once-daily maintenance treatment of asthma in adults and adolescents, which it has since approved.

William Mezzanotte, head of respiratory medicine at Boehringer Ingelheim, stated that this approval "establishes a new class of inhaled asthma therapy and provides an efficacious, new option for patients.”

The medication’s asthma indication is based on clinical evidence that showed the treatment significantly improved lung function in patients aged 12 years or older with asthma who remained symptomatic on at least an inhaled corticosteroid (ICS).

For asthma, Spiriva Respimat is approved as a once-daily dose of 2.5 µg, delivered in 2 puffs of 1.25 µg each. For COPD, it is approved as a once-daily dose of 5 µg, delivered in 2 puffs of 2.5 µg each.

The most common side effects with Spiriva Respimat in patients with asthma are sore throat, sinus infection, bronchitis, and headache. It is not a treatment for sudden asthma symptoms.

Related Videos
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.